Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ERYTHROMYCIN Cause Swollen joint count increased? 75 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 75 reports of Swollen joint count increased have been filed in association with ERYTHROMYCIN (Erythromycin). This represents 1.0% of all adverse event reports for ERYTHROMYCIN.

75
Reports of Swollen joint count increased with ERYTHROMYCIN
1.0%
of all ERYTHROMYCIN reports
75
Deaths
75
Hospitalizations

How Dangerous Is Swollen joint count increased From ERYTHROMYCIN?

Of the 75 reports, 75 (100.0%) resulted in death, 75 (100.0%) required hospitalization, and 75 (100.0%) were considered life-threatening.

Is Swollen joint count increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ERYTHROMYCIN. However, 75 reports have been filed with the FAERS database.

What Other Side Effects Does ERYTHROMYCIN Cause?

Drug hypersensitivity (3,813) Nausea (560) Drug ineffective (502) Vomiting (497) Rash (471) Hypersensitivity (401) Diarrhoea (378) Urticaria (361) Dyspnoea (344) Fatigue (344)

What Other Drugs Cause Swollen joint count increased?

METHOTREXATE (2,068) ABATACEPT (2,032) TOCILIZUMAB (1,987) RITUXIMAB (1,973) ADALIMUMAB (1,933) DICLOFENAC (1,916) LEFLUNOMIDE (1,907) FOLIC ACID (1,898) PREDNISONE (1,882) ALENDRONATE (1,880)

Which ERYTHROMYCIN Alternatives Have Lower Swollen joint count increased Risk?

ERYTHROMYCIN vs ERYTHROMYCIN ETHYLSUCCINATE ERYTHROMYCIN vs ERYTHROMYCIN LACTOBIONATE ERYTHROMYCIN vs ERYTHROPOIETIN ERYTHROMYCIN vs ESCHERICHIA COLI ERYTHROMYCIN vs ESCITALOPRAM

Related Pages

ERYTHROMYCIN Full Profile All Swollen joint count increased Reports All Drugs Causing Swollen joint count increased ERYTHROMYCIN Demographics